Skip to content

Physical activity and exercise in adults with congenital heart disease

The effect of exercise training versus control on vascular endothelial function, cardiorespiratory fitness, strength and quality of life in adults with congenital heart disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000936820
Enrollment
30
Registered
2012-09-04
Start date
2012-10-10
Completion date
2014-10-20
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will investigate the effects of exercise training in adults with congenital heart disease. Thirty patients with congenital heart disease will be randomised to either a 12 week exercise training program, or control group who will mainatin their usual activities, to review the effect on vascular function, cardiorespiratory fitness, muscle strength and quality of life.

Interventions

The exercise intervention will involve 12 weeks of exercise training involving aerobic and resistance modalities. Training will be performed for approximately one hour, three times a week. Initial sessions will be supervised by an exercise physiologist/physiotherapist and then the participant will exercise independently at a community gymnasium. Aerobic exercise will commence at 50% of the baseline VO2peak and progress to 70% of the VO2peak by the end of the intervention period. Resistance exerc

The exercise intervention will involve 12 weeks of exercise training involving aerobic and resistance modalities. Training will be performed for approximately one hour, three times a week. Initial sessions will be supervised by an exercise physiologist/physiotherapist and then the participant will exercise independently at a community gymnasium. Aerobic exercise will commence at 50% of the baseline VO2peak and progress to 70% of the VO2peak by the end of the intervention period. Resistance exercise will commence at 50% of the one-repetition maximum and progress to 70% of the one repletion maximum by the end of the intervention period.

Sponsors

Royal Perth Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Patients aged at least 18 years of age who had previously undergone a Fontan procedure, repaired tetralogy of Fallot, arterial switch operation for transposition of great arteries (including Mustard and Senning procedures), as well as patients with uncorrected congenital heart morphology.

Exclusion criteria

History of life-threatening arrhythmias in the absence of an automatic internal cardiac defibrillator Uncontrolled heart failure (ie, requiring hospitalization and/or intravenous medications within the last month) Severe aortic stenosis; resting peak systolic gradient >50 mm Hg Severe pulmonary stenosis, resting peak systolic gradient >50 mm Hg Severe systemic atrioventricular valve regurgitation Unmedicated systemic hypertension (>165/100mmHg) Pregnancy, or planning to become pregnant during the course of the study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026